메뉴 건너뛰기




Volumn 23, Issue 7, 2012, Pages 1899-1905

153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patients

Author keywords

153samarium EDTMP administration; Hematopoietic stem cell rescue; Metastatic osteosarcoma

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; LEXIDRONAM SAMARIUM SM 153; MORPHINE; NARCOTIC ANALGESIC AGENT; PARACETAMOL; ORGANOMETALLIC COMPOUND; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; SAMARIUM ETHYLENEDIAMINETETRAMETHYLENEPHOSPHONATE;

EID: 84864292921     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr542     Document Type: Article
Times cited : (21)

References (33)
  • 1
    • 0022656434 scopus 로고
    • The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity
    • 31425
    • Link MP, Miser AW, Green AA et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986; 31425: 1600-1606.
    • (1986) N Engl J Med , pp. 1600-1606
    • Link, M.P.1    Miser, A.W.2    Green, A.A.3
  • 2
    • 0027946691 scopus 로고
    • Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases
    • Ward WG, Mikaelian K, Dorey F et al. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol 1994; 12: 1849-1858.
    • (1994) J Clin Oncol , vol.12 , pp. 1849-1858
    • Ward, W.G.1    Mikaelian, K.2    Dorey, F.3
  • 3
    • 0037089598 scopus 로고    scopus 로고
    • High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study
    • Fagioli F, Aglietta M, Tienghi A et al. High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study. J Clin Oncol 2002; 20: 2150-2156.
    • (2002) J Clin Oncol , vol.20 , pp. 2150-2156
    • Fagioli, F.1    Aglietta, M.2    Tienghi, A.3
  • 4
    • 3543081513 scopus 로고    scopus 로고
    • High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas
    • Kasper B, Lehnert T, Bernd L et al. High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas. Bone Marrow Transplant 2004; 34: 37-41.
    • (2004) Bone Marrow Transplant , vol.34 , pp. 37-41
    • Kasper, B.1    Lehnert, T.2    Bernd, L.3
  • 5
    • 59149095843 scopus 로고    scopus 로고
    • Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients
    • Bielack SS, Kempf-Bielack B, Branscheid D et al. Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. J Clin Oncol 2009; 27: 557-565.
    • (2009) J Clin Oncol , vol.27 , pp. 557-565
    • Bielack, S.S.1    Kempf-Bielack, B.2    Branscheid, D.3
  • 6
    • 77953662028 scopus 로고    scopus 로고
    • The role of radiotherapy in osteosarcoma
    • Schwarz R, Bruland O, Cassoni A et al. The role of radiotherapy in osteosarcoma. Cancer Treat Res 2009; 152: 147-164.
    • (2009) Cancer Treat Res , vol.152 , pp. 147-164
    • Schwarz, R.1    Bruland, O.2    Cassoni, A.3
  • 7
    • 0031417685 scopus 로고    scopus 로고
    • A dose-controlled study of 153Smethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases
    • Resche I, Chatal JF, Pecking A et al. A dose-controlled study of 153Smethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. Eur J Cancer 1997; 33: 1583-1591.
    • (1997) Eur J Cancer , vol.33 , pp. 1583-1591
    • Resche, I.1    Chatal, J.F.2    Pecking, A.3
  • 8
    • 0034960433 scopus 로고    scopus 로고
    • Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis
    • Serafini AN. Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis. Q J Nucl Med 2001; 45: 91-99.
    • (2001) Q J Nucl Med , vol.45 , pp. 91-99
    • Serafini, A.N.1
  • 9
    • 0036137678 scopus 로고    scopus 로고
    • High-dose samarium-153 ethylenediamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases
    • Anderson PM, Wiseman GA, Dispenzieri A et al. High-dose samarium-153 ethylenediamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases. J Clin Oncol 2002; 20: 189-196.
    • (2002) J Clin Oncol , vol.20 , pp. 189-196
    • Anderson, P.M.1    Wiseman, G.A.2    Dispenzieri, A.3
  • 10
    • 26444443542 scopus 로고    scopus 로고
    • Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma
    • Anderson PM, Wiseman GA, Erlandson L et al. Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma. Clin Cancer Res 2005; 11: 6895-6900.
    • (2005) Clin Cancer Res , vol.11 , pp. 6895-6900
    • Anderson, P.M.1    Wiseman, G.A.2    Erlandson, L.3
  • 11
    • 33644837672 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy with highdose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups
    • Ferrari S, Smeland S, Mercuri M et al. Neoadjuvant chemotherapy with highdose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 2005; 23: 8845-8852.
    • (2005) J Clin Oncol , vol.23 , pp. 8845-8852
    • Ferrari, S.1    Smeland, S.2    Mercuri, M.3
  • 12
    • 0036189675 scopus 로고    scopus 로고
    • EORTC Soft Tissue and Bone Sarcoma Group. Progression-free rate as the principal end-point for phase II trials in soft tissue sarcomas
    • Van Glabbeke M, Verweeij J, Judson I, Nielsen OS. EORTC Soft Tissue and Bone Sarcoma Group. Progression-free rate as the principal end-point for phase II trials in soft tissue sarcomas. Eur J Cancer 2002; 38: 543-549.
    • (2002) Eur J Cancer , vol.38 , pp. 543-549
    • Van Glabbeke, M.1    Verweeij, J.2    Judson, I.3    Nielsen, O.S.4
  • 13
    • 34247586993 scopus 로고    scopus 로고
    • Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: results of a phase II trial
    • Dileo P, Morgan JA, Zahrieh D et al. Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: results of a phase II trial. Cancer 2007; 109: 1863-1869.
    • (2007) Cancer , vol.109 , pp. 1863-1869
    • Dileo, P.1    Morgan, J.A.2    Zahrieh, D.3
  • 14
    • 33646401788 scopus 로고    scopus 로고
    • RECIST revisited: a review of validation studies on tumour assessment
    • Therasse P, Eisenhauer EA, Verweij J. RECIST revisited: a review of validation studies on tumour assessment. Eur J Cancer 2006; 42: 1031-1039.
    • (2006) Eur J Cancer , vol.42 , pp. 1031-1039
    • Therasse, P.1    Eisenhauer, E.A.2    Verweij, J.3
  • 15
    • 10744228140 scopus 로고    scopus 로고
    • CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment
    • Trotti A, Colevas AD, Setser A et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003; 13: 176-181.
    • (2003) Semin Radiat Oncol , vol.13 , pp. 176-181
    • Trotti, A.1    Colevas, A.D.2    Setser, A.3
  • 16
    • 0026750068 scopus 로고
    • Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer
    • Farhanghi M, Holmes RA, Volkert WA et al. Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer. J Nucl Med 1992; 33: 1451-1458.
    • (1992) J Nucl Med , vol.33 , pp. 1451-1458
    • Farhanghi, M.1    Holmes, R.A.2    Volkert, W.A.3
  • 17
    • 0027958545 scopus 로고
    • Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases
    • Bayouth JE, Macey DJ, Kasi LP, Fossella VF. Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases. J Nucl Med 1994; 35: 63-69.
    • (1994) J Nucl Med , vol.35 , pp. 63-69
    • Bayouth, J.E.1    Macey, D.J.2    Kasi, L.P.3    Fossella, V.F.4
  • 18
    • 14844362344 scopus 로고    scopus 로고
    • Dosimetry of internal emitters
    • Sgouros G. Dosimetry of internal emitters. J Nucl Med 2005; 46: 18S-27S.
    • (2005) J Nucl Med , vol.46
    • Sgouros, G.1
  • 19
    • 0027253922 scopus 로고
    • Samarium-153-EDTMP biodistribution and dosimetry estimation
    • Eary JF, Collins C, Stabin M et al. Samarium-153-EDTMP biodistribution and dosimetry estimation. J Nucl Med 1993; 34: 1031-1036.
    • (1993) J Nucl Med , vol.34 , pp. 1031-1036
    • Eary, J.F.1    Collins, C.2    Stabin, M.3
  • 21
    • 0014559581 scopus 로고
    • Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom
    • MIRD Pamphlet No. 5
    • Snyder WS, Fisher HL, Jr, Ford MR, Warner GG. Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. J Nucl Med 1969; 10: 5-52. MIRD Pamphlet No. 5.
    • (1969) J Nucl Med , vol.10 , pp. 5-52
    • Snyder, W.S.1    Fisher Jr., H.L.2    Ford, M.R.3    Warner, G.G.4
  • 22
    • 0023267570 scopus 로고
    • Radiation dose calculations in persons receiving injection of Sm-153-EDTMP
    • Logan K, Volkert W, Holmes R. Radiation dose calculations in persons receiving injection of Sm-153-EDTMP. J Nucl Med 1987; 28: 505-509.
    • (1987) J Nucl Med , vol.28 , pp. 505-509
    • Logan, K.1    Volkert, W.2    Holmes, R.3
  • 23
    • 33845382806 scopus 로고
    • Non parametric estimation from incomplete observation
    • Kaplan EL, Meier P. Non parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-481.
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 24
    • 0000336139 scopus 로고
    • Regression models and life tables
    • Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187-202.
    • (1972) J R Stat Soc , vol.34 , pp. 187-202
    • Cox, D.R.1
  • 25
    • 84972545970 scopus 로고
    • A survey of exact inference for contingency tables
    • Agresti A. A survey of exact inference for contingency tables. Stat Sci 1992; 7: 131-177.
    • (1992) Stat Sci , vol.7 , pp. 131-177
    • Agresti, A.1
  • 26
    • 33748125999 scopus 로고    scopus 로고
    • Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients
    • Bacci G, Longhi A, Bertoni F et al. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients. Acta Orthop 2006; 77: 938-943.
    • (2006) Acta Orthop , vol.77 , pp. 938-943
    • Bacci, G.1    Longhi, A.2    Bertoni, F.3
  • 27
    • 0037440140 scopus 로고    scopus 로고
    • Metachronous skeletal osteosarcoma in patients treated with adjuvant and neoadjuvant chemotherapy for nonmetastatic osteosarcoma
    • Aung L, Gorlick R, Healey JH et al. Metachronous skeletal osteosarcoma in patients treated with adjuvant and neoadjuvant chemotherapy for nonmetastatic osteosarcoma. J Clin Oncol 2003; 21: 342-348.
    • (2003) J Clin Oncol , vol.21 , pp. 342-348
    • Aung, L.1    Gorlick, R.2    Healey, J.H.3
  • 28
    • 0345707587 scopus 로고    scopus 로고
    • Single and multiple metachronous osteosarcoma tumors after therapy
    • Jaffe N, Pearson P, Yasko AW et al. Single and multiple metachronous osteosarcoma tumors after therapy. Cancer 2003; 98: 2457-2466.
    • (2003) Cancer , vol.98 , pp. 2457-2466
    • Jaffe, N.1    Pearson, P.2    Yasko, A.W.3
  • 29
    • 66649106084 scopus 로고    scopus 로고
    • Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma
    • Loeb DM, Garrett-Mayer E, Hobbs RF et al. Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma. Cancer 2009; 115: 2514-2522.
    • (2009) Cancer , vol.115 , pp. 2514-2522
    • Loeb, D.M.1    Garrett-Mayer, E.2    Hobbs, R.F.3
  • 30
    • 78649594834 scopus 로고    scopus 로고
    • Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma
    • Loeb DM, Hobbs RF, Okoli A et al. Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma. Cancer 2010; 116: 5470-5478.
    • (2010) Cancer , vol.116 , pp. 5470-5478
    • Loeb, D.M.1    Hobbs, R.F.2    Okoli, A.3
  • 31
    • 33644874921 scopus 로고    scopus 로고
    • Intraorgan biodistribution and dosimetry of 153Sm-ethylene-diaminetetramethylene phosphonate in juvenile rabbit tibia: implication for targeted radiotherapy of osteosarcoma
    • Essman SC, Lewis MR, Miller WH. Intraorgan biodistribution and dosimetry of 153Sm-ethylene-diaminetetramethylene phosphonate in juvenile rabbit tibia: implication for targeted radiotherapy of osteosarcoma. J Nucl Med 2005; 46: 2076-2082.
    • (2005) J Nucl Med , vol.46 , pp. 2076-2082
    • Essman, S.C.1    Lewis, M.R.2    Miller, W.H.3
  • 32
    • 0242267007 scopus 로고    scopus 로고
    • The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning
    • Kramer M, Weyrather WK, Scholz M. The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning. Technol Cancer Res Treat 2003; 2: 427-436.
    • (2003) Technol Cancer Res Treat , vol.2 , pp. 427-436
    • Kramer, M.1    Weyrather, W.K.2    Scholz, M.3
  • 33
    • 33746707858 scopus 로고    scopus 로고
    • High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?
    • Bruland ØS, Nilsson S, Fisher DR, Larsen RH. High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?. Clin Cancer Res 2006; 12(20 Pt 2): 6250s-6257s.
    • (2006) Clin Cancer Res , vol.12 , Issue.20 PART 2
    • Bruland, Ø.S.1    Nilsson, S.2    Fisher, D.R.3    Larsen, R.H.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.